Какова цена за Synmosa Biopharma Corporation (4114)

Цена за Synmosa Biopharma Corporation (4114) Это $0.94761103

Какова рыночная капитализация для Synmosa Biopharma Corporation (4114)

Рыночная капитализация для Synmosa Biopharma Corporation (4114) Это $511.40M

Synmosa Biopharma Corporation (4114) EPS

Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.

Год	EPS	Изменить
Недостаточно данных для указанных дат.

Год

EPS

Изменить

Недостаточно данных для указанных дат.

Компания	EPS	Разница в EPS	Страна
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN
Galderma Group AG GALD.SW	-	-	CH

Компания

EPS

Разница в EPS

Страна